Company: GRCE
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001140361-25-030398
Chunk: 46

Company: Grace Therapeutics, Inc.
Filing Date: 2025-08-12
Form: 10-Q
Item: Item 8
Chunk 46
---
5-06-30

    0001444192
    
      srt:WeightedAverageMember
      grce:CommonWarrants2023Member

    2025-04-01
    2025-06-30

    0001444192
    
      srt:WeightedAverageMember
      grce:CommonWarrants2023Member

    2024-04-01
    2025-03-31

    0001444192
    
      us-gaap:RelatedPartyMember

    2025-06-30

    0001444192
    
      us-gaap:RelatedPartyMember

    2025-03-31

    0001444192
    
      grce:CommonWarrants2023Member

    2025-06-30

    0001444192
    
      grce:PrefundedWarrants2023Member

    2025-06-30

    0001444192
    
      grce:CommonWarrants2025Member

    2025-06-30

    0001444192
    
      grce:PrefundedWarrants2025Member

    2025-06-30

    0001444192
    
      us-gaap:MeasurementInputRiskFreeInterestRateMember

    2025-06-30

    0001444192
    
      us-gaap:MeasurementInputRiskFreeInterestRateMember

    2025-03-31

    0001444192
    
      us-gaap:MeasurementInputSharePriceMember

    2025-06-30

    0001444192
    
      us-gaap:MeasurementInputSharePriceMember

    2025-03-31

    0001444192
    
      us-gaap:MeasurementInputExpectedTermMember

    2025-06-30

    0001444192
    
      us-gaap:MeasurementInputExpectedTermMember

    2025-03-31

    0001444192
    
      us-gaap:MeasurementInputExpectedDividendRateMember

    2025-06-30

    0001444192
    
      us-gaap:MeasurementInputExpectedDividendRateMember

    2025-03-31

    0001444192
    
      us-gaap:MeasurementInputPriceVolatilityMember